KIAA0101 Produkte
(PCNA Clamp Associated Factor (PAF))
Kategorien
antibodies-online.com steht für hochwertige Forschungsprodukte. Suchen, finden und bestellen Sie Tools mit umfangreichen Validierungsdaten, Bildern, Referenzen. Unser wissenschaftlicher Kundenservice steht Ihnen jederzeit zur Verfügung, wenn Sie Fragen zur Auswahl oder Anwendung unserer Produkte haben.
Ausgewählte KIAA0101 Kategorien
KIAA0101 Antikörper
High quality antibodies with extensive validation data.
KIAA0101 ELISA Kits
Reliable ELISA kits for a wide range of species.
KIAA0101 Proteine
Proteins for various applications incl. WB, ELISA, IF etc.
Empfohlene KIAA0101 Antikörper
- (6)
- (5)
- (5)
- (2)
Empfohlene KIAA0101 ELISA Kits
- (1)
- (1)
- (1)
Empfohlene KIAA0101 Proteine
- (1)
- (1)
Neueste Publikationen zu unseren KIAA0101 Produkten
: "KIAA0101 is a novel transcriptional target of FoxM1 and is involved in the regulation of hepatocellular carcinoma microvascular invasion by regulating epithelial-mesenchymal transition." in: Journal of Cancer, Vol. 10, Issue 15, pp. 3501-3516, (2019) (PubMed).: "Paf15 expression correlates with rectal cancer prognosis, cell proliferation and radiation response." in: Oncotarget, Vol. 7, Issue 25, pp. 38750-38761, (2018) (PubMed).
: "Levels of thrombin-activatable fibrinolysis inhibitor and platelet-activating factor in recurrent pregnancy loss patients." in: Taiwanese journal of obstetrics & gynecology, Vol. 55, Issue 1, pp. 60-3, (2016) (PubMed).
: "NS5ATP9 mRNA levels in peripheral blood mononuclear cells predict prognosis in patients with gastric cancer." in: Medical oncology (Northwood, London, England), Vol. 31, Issue 8, pp. 106, (2014) (PubMed).
: "Correlation of platelet activating factor and age-related macular degeneration." in: Expert opinion on therapeutic targets, Vol. 18, Issue 9, pp. 987-97, (2014) (PubMed).
: "Elevated cyclin B2 expression in invasive breast carcinoma is associated with unfavorable clinical outcome." in: BMC cancer, Vol. 13, pp. 1, (2013) (PubMed).
: "p15(PAF) is an Rb/E2F-regulated S-phase protein essential for DNA synthesis and cell cycle progression." in: PLoS ONE, Vol. 8, Issue 4, pp. e61196, (2013) (PubMed).
: "Expression of KIAA0101 protein is associated with poor survival of esophageal cancer patients and resistance to cisplatin treatment in vitro." in: Laboratory investigation; a journal of technical methods and pathology, Vol. 93, Issue 12, pp. 1276-87, (2013) (PubMed).
: "Immune complexes isolated from patients with pulmonary tuberculosis modulate the activation and function of normal granulocytes." in: Clinical and vaccine immunology : CVI, Vol. 19, Issue 12, pp. 1965-71, (2012) (PubMed).
: "Overexpression of KIAA0101 predicts poor prognosis in primary lung cancer patients." in: Lung cancer (Amsterdam, Netherlands), Vol. 75, Issue 1, pp. 110-8, (2011) (PubMed).
Synonyme und alternative Namen zu KIAA0101
PCNA clamp associated factor (PCLAF), PCNA clamp associated factor (pclaf), PCNA clamp associated factor S homeolog (pclaf.S), PCNA clamp associated factor (Pclaf), AA409629, Kiaa0101, mKIAA0101, Ns5apt9, NS5ATP9, Ns5atp9, OEATC, OEATC-1, OEATC1, p15(PAF), p15/PAF, p15PAF, PAF, paf, Paf, PAF15Bezeichner auf Proteinebene für KIAA0101
- HCV NS5A-transactivated protein 9
- PCNA-associated factor
- PCNA-associated factor of 15 kDa
- hepatitis C virus NS5A-transactivated protein 9
- overexpressed in anaplastic thyroid carcinoma 1
- uncharacterized protein LOC496365
- p15PAF
- PCNA-associated factor-like
- HCV NS5A-transactivated protein 9 homolog